International health experts, scientists and policymakers from Harvard University’s Science of Defeating Malaria initiative have lauded the establishment of the NASENI-Troment Biotechnologies factory, describing it as a significant milestone in the fight against malaria and other infectious diseases in Nigeria and across Africa.
The delegation made the commendation during a tour of the multi-million-dollar diagnostic manufacturing facility in Abuja on Sunday. The visitors expressed admiration for the factory’s capacity to produce Polymerase Chain Reaction (PCR) kits and Rapid Diagnostic Tests (RDTs), noting that the initiative represents a significant milestone in the development of a wholly Nigerian-owned diagnostic brand.
Speaking during the tour, Chief Executive Officer and Co-Founder of NASENI-Troment Biotechnologies, Selim Hani, said the facility was established through a strategic partnership between the National Agency for Science and Engineering Infrastructure (NASENI) and Troment Nigeria Limited to strengthen Nigeria’s healthcare sovereignty through local production of diagnostic technologies.
According to him, the factory, which was built within 18 months, focuses on the manufacturing of RDTs and other in-vitro diagnostic products to support the early detection of infectious and public health diseases.
Hani disclosed that diagnostic kits under the N-CheckUP brand would be used for testing malaria, Hepatitis B and C, HIV 1 and 2, pregnancy, COVID-19 antigen, typhoid, syphilis and blood glucose, among other health conditions.
He added that the facility has the capacity to produce up to 600 million diagnostic kits annually, significantly reducing Nigeria’s and West Africa’s dependence on imported medical diagnostics while improving access to affordable healthcare solutions across the region.
Also speaking, Technical Partner of NASENI-Troment Biotechnologies, Dr. Engin Narinc, described the factory as Africa’s first fully localized Rapid Diagnostic Test kit manufacturing facility.
“From concept to full-scale launch, our end-to-end production process is designed to deliver world-class diagnostic solutions built entirely in Africa, for Africa,” he said.
Leading the Harvard delegation on the tour, Professor Dyann F. Wirth, Team Lead of the Science of Defeating Malaria Initiative and one of the world’s foremost malaria researchers, described the facility as a remarkable achievement with the potential to contribute significantly to the fight against malaria and other public health challenges on the continent.
“This is an amazing facility that would add value to the eradication of malaria and other public health diseases in Nigeria and Africa,” she said.
The Science of Defeating Malaria leadership development programme, currently taking place in Abuja from June 7 to 13, 2026, brings together global health professionals, scientists and policymakers committed to advancing efforts aimed at the elimination and eventual eradication of malaria worldwide.
Comment here